Pharmacies Can Produce Promising Covid-19 Drug, FDA Says

Hospitals will have more options to buy a promising Covid-19 treatment that’s been in short supply for a month, thanks to relaxed production regulations the FDA announced Tuesday.

Facilities such as pharmacies have the green light to produce intravenous dexamethasone and sell it to hospitals that can’t get it from their regular suppliers. Those sorts of drug production facilities are less regulated by the Food and Drug Administration than standard drug manufacturers but still have to uphold certain industry production and reporting standards.

The IV version of the generic steroid has been in short supply since mid-June after research showed ...